Gainers
Fulcrum Therapeutics, Inc. (NASDAQ: FULC) jumped 125.3% to close at $18.77 on Tuesday after the company announced positive interim results from the Phase 1 trial with FTX-6058 in healthy adult volunteers.
Shares of BRP Group (NASDAQ:BRP) rose in after-market trading after the company reported Q2 results.
Quarterly Results
Earnings per share increased 40.00% year over year to $0.14, which beat the estimate of $0.09.
BRP Group (NASDAQ:BRP) reported quarterly earnings of $0.14 per share which beat the analyst consensus estimate of $0.09 by 55.56 percent. This is a 40 percent increase over earnings of $0.10 per share from the same
Companies Reporting Before The Bell
• Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $1.57 per share on revenue of $215.17 million.
BRP Group, Inc. ("BRP Group" or the "Company") (NASDAQ:BRP), an independent insurance distribution firm delivering tailored insurance solutions, through its indirect subsidiaries, today has entered